DerspasWhite

DerspasWhite is a medication used to treat uterine bleeding associated with hormonal imbalance, menopausal bleeding, and bleeding after menstrual periods. It belongs to the class of medications known as progesterone agonists or progestins, which mimic the effects of the female hormone progesterone.

The active ingredient in DerspasWhite is dydrogesterone, a synthetic progestin that has a longer duration of action compared to other progestins. This allows for once-daily dosing, which can improve patient compliance and convenience. DerspasWhite is available in various strengths, including tablets and capsules, which are available in different formulations to suit individual patient needs.

Studies have shown that DerspasWhite is effective in treating various forms of uterine bleeding, including those associated with hormonal imbalances and menopausal changes. It works by promoting a period of new tissue growth and promoting a return to normal bleeding patterns. In clinical trials, DerspasWhite has been well-tolerated, with side effects being mild and transient in most cases.

DerspasWhite is typically administered once daily for a specified period, usually 3-6 months, depending on the patient's condition and clinical response. The medication is often used in combination with other treatments, such as hormone replacement therapy, to manage symptoms of hormonal imbalance and menopause. While generally considered safe, as with any medication, DerspasWhite may not be suitable for all patients, particularly those with a history of allergic reactions or sensitivity to progestins. Patients should consult with their healthcare provider to determine the best course of treatment.